Exact Mass: 456.138666
Exact Mass Matches: 456.138666
Found 500 metabolites which its exact mass value is equals to given mass value 456.138666,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flavin mononucleotide
Flavin mononucleotide, also known as riboflavin 5-monophosphate or riboflavine dihydrogen phosphate, is a member of the class of compounds known as flavin nucleotides. Flavin nucleotides are nucleotides containing a flavin moiety. Flavin is a compound that contains the tricyclic isoalloxazine ring system, which bears 2 oxo groups at the 2- and 4-positions. Flavin mononucleotide is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Flavin mononucleotide can be found in a number of food items such as spinach, elliotts blueberry, tea leaf willow, and black mulberry, which makes flavin mononucleotide a potential biomarker for the consumption of these food products. Flavin mononucleotide can be found primarily in blood, as well as throughout most human tissues. Flavin mononucleotide exists in all living species, ranging from bacteria to humans. In humans, flavin mononucleotide is involved in several metabolic pathways, some of which include riboflavin metabolism, pyrimidine metabolism, beta-alanine metabolism, and doxorubicin metabolism pathway. Flavin mononucleotide is also involved in several metabolic disorders, some of which include beta ureidopropionase deficiency, UMP synthase deficiency (orotic aciduria), carnosinuria, carnosinemia, and hypophosphatasia. Moreover, flavin mononucleotide is found to be associated with anorexia nervosa. Flavin mononucleotide (FMN), or riboflavin-5′-phosphate, is a biomolecule produced from riboflavin (vitamin B2) by the enzyme riboflavin kinase and functions as prosthetic group of various oxidoreductases including NADH dehydrogenase as well as cofactor in biological blue-light photo receptors. During the catalytic cycle, a reversible interconversion of the oxidized (FMN), semiquinone (FMNH•) and reduced (FMNH2) forms occurs in the various oxidoreductases. FMN is a stronger oxidizing agent than NAD and is particularly useful because it can take part in both one- and two-electron transfers. In its role as blue-light photo receptor, (oxidized) FMN stands out from the conventional photo receptors as the signaling state and not an E/Z isomerization . Flavin mononucleotide (FMN), or riboflavin-5′-phosphate, is a biomolecule produced from riboflavin (vitamin B2) by the enzyme riboflavin kinase and functions as the prosthetic group of various oxidoreductases, including NADH dehydrogenase, as well as cofactor in biological blue-light photo receptors. During the catalytic cycle, a reversible interconversion of the oxidized (FMN), semiquinone (FMNH), and reduced (FMNH2) forms occurs in the various oxidoreductases. FMN is a stronger oxidizing agent than NAD and is particularly useful because it can take part in both one- and two-electron transfers. In its role as blue-light photo receptor, (oxidized) FMN stands out from the conventional photo receptors as the signaling state and not an E/Z isomerization. It is the principal form in which riboflavin is found in cells and tissues. It requires more energy to produce, but is more soluble than riboflavin. Flavin mononucleotide belongs to the class of organic compounds known as flavin nucleotides. These are nucleotides containing a flavin moiety. Flavin is a compound that contains the tricyclic isoalloxazine ring system, which bears 2 oxo groups at the 2- and 4-positions. Flavin mononucleotide exists in all living species, ranging from bacteria to humans. Within humans, flavin mononucleotide participates in a number of enzymatic reactions. In particular, formic acid and flavin mononucleotide can be biosynthesized from FMNH2; which is catalyzed by the enzyme lanosterol 14-alpha demethylase. In addition, formic acid and flavin mononucleotide can be biosynthesized from FMNH2 through the action of the enzyme lanosterol 14-alpha demethylase. In humans, flavin mononucleotide is involved in bloch pathway (cholesterol biosynthesis). Outside of the human body, flavin mononucleotide has been detected, but not quantified in several different foods, such as mandarin orange (clementine, tangerine), horseradish tree, black elderberries, angelica, and ostrich ferns. Acquisition and generation of the data is financially supported in part by CREST/JST. D018977 - Micronutrients > D014815 - Vitamins
Epicatechin 3-O-(4-methylgallate)
Epicatechin 3-(4-methylgallate) is a member of the class of compounds known as catechin gallates. Catechin gallates are organic compounds containing a gallate moiety glycosidically linked to a catechin. Thus, epicatechin 3-(4-methylgallate) is considered to be a flavonoid lipid molecule. Epicatechin 3-(4-methylgallate) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Epicatechin 3-(4-methylgallate) can be found in tea, which makes epicatechin 3-(4-methylgallate) a potential biomarker for the consumption of this food product. Epicatechin 3-O-(4-methylgallate) is found in tea. Epicatechin 3-O-(4-methylgallate) is isolated from Camellia sinensis var. assamica (commercial oolong tea).
Atrovirinone
Atrovirinone is found in fruits. Atrovirinone is a constituent of the roots of Garcinia atroviridis (gelugor) Constituent of the roots of Garcinia atroviridis (gelugor). Atrovirinone is found in fruits.
Epicatechin 3-O-(3-O-methylgallate)
Epicatechin 3-O-(3-O-methylgallate) is found in tea. Epicatechin 3-O-(3-O-methylgallate) is isolated from green China tea (Camellia sinensis) leaves. Isolated from green China tea (Camellia sinensis) leaves. Epicatechin 3-(3-methylgallate) is found in tea.
5-S-Glutathionyl-aminochrome reduced
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
3-Hydroxymethyl-picumast
C25H29ClN2O4 (456.18157440000004)
3-(Glutathion-S-yl)acetaminophen
Azilsartan
Indoxam
Dilmapimod
C23H19F3N4O3 (456.14091800000006)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
C23H28N4O4S (456.18311680000005)
15-Demethyl plumieride
(S)-(+)-Tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
Lactupicrin methyl ester
Lactupicrin methyl ester is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lactupicrin methyl ester can be found in chicory, which makes lactupicrin methyl ester a potential biomarker for the consumption of this food product.
2,15-dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-1(26),3(30),4,6,10(29),11,13,16(21),17,19,24,27-dodecaene-4,5,8,17-tetrol 1
CONFIDENCE Predicted
11,5-Dihydroxy-2,3,4-trimethoxy-6,6-dimethyl-4,5-dihydropyrano[2,3:9,8]-6a,12a-didehydrorotenone
aspernigrin B
A pyridine alkaloid with formula C27H24N2O5 that is isolated from Aspergillus niger and displays neuroprotective protperties.
Lobaric acid
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
2-[3,5-Dimethoxy-4-[(3-methyl-2-butenyl)oxy]phenyl]-5,6,7-trimethoxy-4H-1-benzopyran-4-one
3,5,7-Tris(acetyloxy)-8-methoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one
6-O-[(2E)-3-(4-Hydroxyphenyl)-2-propenoyl]-1-O-[(2E)-3-phenyl-2-propenoyl]-β-D-glucopyranose
11-(2-bromo-3,6-dimethoxyphenyl)-3,3-dimethyl-2,3,4-trihydro-5H,10H,11H-benzo[ b]benzo[2,1-f]1,4-diazepin-1-one
C23H25BrN2O3 (456.10484399999996)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.125 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.123 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.128 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.127
(2R,3R)-3,3,4,5,7-tetrahydroxy-3-methoxy-6-[6-hydroxy-3,7-dimethyl-2(E),7-octadienyl]flavanone
3,4-ethylenedioxy-5-hydroxy-3-(1-hydroxy-1-methylethyl)-6,7-dimethyl-5-methoxyflavone-8-carboxylic acid
alpha-Pyranose-alpha-L-Rhamnopyranosyl-(1鈥樏傗垎3)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎3)-L-rhamnose|beta-Pyranose-alpha-D-Rhamnopyranosyl-(1鈥樏傗垎3)-alpha-D-rhamnopyranosyl-(1鈥樏傗垎2)-L-rhamnose
Dehydroaustinol
A meroterpenoid produced by Aspergillus nidulans. It has an oxygen-bridged pentacyclic structure which incorporates three lactone functionalities and a spiro union.
3,3,4,5,8-Penta-Me ether,7-O-(3-methyl-2-butenyl)-Gossypetin
4-(beta-D-glucopyranosyloxy)-6-methyl-2H-pyran-2-one tetraacetate
4,5,7-Triacetoxy-3,6-dimethoxy-flavon (synth. Jaceosidin-triacetat)|5,7,4-Triacetoxy-3,6-dimethoxy-flavon|5,7,4-Triacetoxy-6,3-dimethoxy-flavon|5,7-diacetoxy-2-(4-acetoxy-3-methoxy-phenyl)-6-methoxy-chromen-4-one|Jaceosidin-acetat|Jaceosidin-triacetat
ellagic acid 4-O-beta-D-xylopyranoside-3,3-dimethyl ether
O-[beta-D-xylopyranosyl(1->6)-beta-D-glucopyranosyl] 7-hydroxycoumarin|umbelliferone 7-O-beta-D-xylopyranosyl (1->6) beta-D-glucopyranoside
6,7-dimethylbenzofuran-5-yl beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside
C21H28O11 (456.16315380000003)
alpha-D-Rhamnopyranosyl-(1鈥樏傗垎2)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎3)-L-rhamnose|alpha-L-Rhamnopyranosyl-(1鈥樏傗垎2)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎3)-L-rhamnose
7-[(3-methyl-but-2-en-yl)oxy]-5-hydroxy-3,6,8-trimethoxy-3,4-methylenedioxyflavone|7-[(3-methyl-but-2-enyl)oxy]-5-hydroxy-3,6,8-trimethoxy-3,4-methylenedioxyflavone
(-)-epicatechin gallate-4-O-Me|4-O-methyl-(-)-epicatechin gallate|4-O-methylepicatechin-3-O-gallate
8-(7??-hydroxy-3??,7??-dimethyl-oct-2??-enyl)quercetin|solophenol C
2-(7??-hydroxy-3??,7??-dimethyl-oct-2??-enyl)quercetin|solophenol B
2-(1,3-Benzodioxole-5-yl)-3,5,8-trimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
4,6-Dimethoxy-3,5,7-tri-O-acetyl-flavon|5,7-diacetoxy-2-(3-acetoxy-4-methoxy-phenyl)-6-methoxy-chromen-4-one|Tri-Ac-3,5,7-Trihydroxy-4,6-dimethoxyflavone
1,4-Diacetoxy-10-methoxy-5,8,11-trimethyl-1H-benzo[5,6][1,4]dioxepino[3,2-e]isobenzofuran-3,7-dion|1,4-diacetoxy-10-methoxy-5,8,11-trimethyl-1H-benzo[5,6][1,4]dioxepino[3,2-e]isobenzofuran-3,7-dione|hypostictic acid-diacetate
3-methyl-O-[alpha-arabinopyranosyl-(1->6)-beta-glucopyranosyl]-6-methyl-benzofuran
C21H28O11 (456.16315380000003)
1alpha,9beta-difuranoyloxy-2-oxodihydro-beta-agarofuran
3,3-Dimethoxy-2,4-diacetoxy-5-(3-acetoxy-propyl)-stilben|trans-2,4-diacetoxy-5-(3-acetoxypropyl)-3,3-dimethoxystilbene
(1S,3aR,4S,9aR)-4-(4-acetoxy-3-methoxyphenyl)-1,7-dimethoxy-1,3,3a,4,9,9a-hexahydronaphtho<2,3-c>furan-6-yl acetate|formosanol diacetate|Methyl-alpha-conidendraldiacetat|tsugacetal diacetate
2(S)-5,6,7-trihydroxy-5-prenyl-[2,2-(3,4-dihydroxy)-dimethylpyrano]-(5,6:3,4)flavanone
2-acetyl-1-coumaroyl-3-feruloylglycerol|2-acetyl-1-[(E)-p-coumaroyl]-3-[(E)-feruloyl]glycerol
alpha-Pyranose-alpha-L-Rhamnopyranosyl-(1鈥樏傗垎3)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎2)-L-rhamnose
1-O-cinnamoyl-6-O-p-coumaroyl-beta-D-glucopyranoside
Asp Ala His Asp
9-keto Fluprostenol
C23H27F3O6 (456.17596380000003)
PF-3845
PF-3845 is a potent, selective, irreversible and orally active inhibitor of fatty acid amide hydrolase (FAAH), with a Ki of 0.23 μM. PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile. PF-3845 can reduce pain sensation, inflammation, and anxiety/depression without substantial effects on motility or cognition[1][3].
11-keto Fluprostenol
C23H27F3O6 (456.17596380000003)
(E)-1-(glutathion-S-yl)-N-hydroxy-2-(4-hydroxyphenyl)ethan-1-imine
adicardin
Apiosylskimmin is a natural product found in Gmelina arborea, Angelica pubescens, and other organisms with data available.
Riboflavine phosphate
C17H21N4O9P (456.10461060000006)
7-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxychromen-2-one
7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one
6-[2,3-dihydroxy-3-methyl-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-7-methoxychromen-2-one
C21H28O11 (456.16315380000003)
C25H28O8_(1S,2R,3R,7R,8R,9S,13R)-8-Hydroxy-2,2,2,9,13-pentamethyl-6,16-bis(methylene)-6H-spiro[pyran-3,5-[10,14,17]trioxapentacyclo[7.6.1.1~7,12~.0~1,12~.0~2,7~]heptadecane]-6,11,15-trione
C24H24O9_6-O-[(2E)-3-(4-Hydroxyphenyl)-2-propenoyl]-1-O-[(2E)-3-phenyl-2-propenoyl]-beta-D-glucopyranose
C25H28O8_12H-6,13-Epoxy-8,12a-methano-2H,7H-furo[3,4:6,7]oxireno[3,4]heptaleno[3,2-c]pyran-4,9,12(6H,8H)-trione, 6a,9a,10,12b,13,13a-hexahydro-9a-hydroxy-2,2,6,8,10,12b-hexamethyl-15-methylene
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl] (E)-3-phenylprop-2-enoate
2-[3,4-dihydroxy-2,2-dimethyl-8-(3-methylbut-2-enoxy)-3,4-dihydrochromen-6-yl]-5,7-dihydroxy-2,3-dihydrochromen-4-one
7-hydroxy-2,6,9,12,17,17-hexamethyl-22-methylidene-5,16,19,21-tetraoxaheptacyclo[10.8.1.1³,⁹.0²,¹¹.0³,⁷.0¹³,¹⁸.0¹⁸,²⁰]docos-13-ene-4,8,15-trione
Flavin mononucleotide
C17H21N4O9P (456.10461060000006)
A flavin mononucleotide that is riboflavin (vitamin B2) in which the primary hydroxy group has been converted to its dihydrogen phosphate ester. D018977 - Micronutrients > D014815 - Vitamins
2,15-dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-1(26),3(30),4,6,10(29),11,13,16(21),17,19,24,27-dodecaene-4,5,8,17-tetrol 2
CONFIDENCE Predicted
7-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxychromen-2-one [IIN-based on: CCMSLIB00000845708]
7-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxychromen-2-one [IIN-based: Match]
Benzanilide, 2,2-dithiobis-
CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5297; ORIGINAL_PRECURSOR_SCAN_NO 5295 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5312; ORIGINAL_PRECURSOR_SCAN_NO 5310 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5270; ORIGINAL_PRECURSOR_SCAN_NO 5265 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5309; ORIGINAL_PRECURSOR_SCAN_NO 5307 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5302; ORIGINAL_PRECURSOR_SCAN_NO 5298 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5305; ORIGINAL_PRECURSOR_SCAN_NO 5304 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7946; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7977; ORIGINAL_PRECURSOR_SCAN_NO 7975 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7986; ORIGINAL_PRECURSOR_SCAN_NO 7982 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8027; ORIGINAL_PRECURSOR_SCAN_NO 8025 CONFIDENCE standard compound; INTERNAL_ID 681; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8030; ORIGINAL_PRECURSOR_SCAN_NO 8028
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl] (E)-3-phenylprop-2-enoate_major
7-hydroxy-2,6,9,12,17,17-hexamethyl-22-methylidene-5,16,19,21-tetraoxaheptacyclo[10.8.1.1³,⁹.0²,¹¹.0³,⁷.0¹³,¹⁸.0¹⁸,²⁰]docos-13-ene-4,8,15-trione_major
2-[3,4-dihydroxy-2,2-dimethyl-8-(3-methylbut-2-enoxy)-3,4-dihydrochromen-6-yl]-5,7-dihydroxy-2,3-dihydrochromen-4-one_major
7-hydroxy-2,6,9,12,17,17-hexamethyl-22-methylidene-5,16,19,21-tetraoxaheptacyclo[10.8.1.1³,?.0²,¹¹.0³,?.0¹³,¹?.0¹?,²?]docos-13-ene-4,8,15-trione
Ala Cys Thr Tyr
Ala Cys Tyr Thr
Ala Asp Asp His
Ala Asp His Asp
Ala His Asp Asp
Ala Thr Cys Tyr
Ala Thr Tyr Cys
Ala Tyr Cys Thr
Ala Tyr Thr Cys
Cys Ala Thr Tyr
Cys Ala Tyr Thr
Cys Cys Met Thr
Cys Cys Thr Met
Cys Asp Gly Tyr
Cys Asp Tyr Gly
Cys Phe Gly Met
Cys Phe Met Gly
Cys Phe Ser Thr
Cys Phe Thr Ser
Cys Gly Asp Tyr
Cys Gly Phe Met
Cys Gly Met Phe
Cys Gly Tyr Asp
Cys His Pro Thr
C18H28N6O6S (456.17909480000003)
Cys His Thr Pro
C18H28N6O6S (456.17909480000003)
Cys Met Cys Thr
Cys Met Phe Gly
Cys Met Gly Phe
Cys Met Thr Cys
Cys Pro His Thr
C18H28N6O6S (456.17909480000003)
Cys Pro Thr His
C18H28N6O6S (456.17909480000003)
Cys Ser Phe Thr
Cys Ser Thr Phe
Cys Thr Ala Tyr
Cys Thr Cys Met
Cys Thr Phe Ser
Cys Thr His Pro
C18H28N6O6S (456.17909480000003)
Cys Thr Met Cys
Cys Thr Pro His
C18H28N6O6S (456.17909480000003)
Cys Thr Ser Phe
Cys Thr Tyr Ala
Cys Tyr Ala Thr
Cys Tyr Asp Gly
Cys Tyr Gly Asp
Cys Tyr Thr Ala
Asp Ala Asp His
Asp Cys Gly Tyr
Asp Cys Tyr Gly
Asp Asp Ala His
Asp Asp His Ala
Asp Glu Gly His
Asp Glu His Gly
Asp Gly Cys Tyr
Asp Gly Glu His
Asp Gly His Glu
Asp Gly Tyr Cys
Asp His Ala Asp
Asp His Asp Ala
Asp His Glu Gly
Asp His Gly Glu
Asp Tyr Cys Gly
Asp Tyr Gly Cys
Glu Asp Gly His
Glu Asp His Gly
Glu Gly Asp His
Glu Gly His Asp
Glu His Asp Gly
Glu His Gly Asp
Phe Cys Gly Met
Phe Cys Met Gly
Phe Cys Ser Thr
Phe Cys Thr Ser
Phe Gly Cys Met
Phe Gly Met Cys
Phe Met Cys Gly
Phe Met Gly Cys
Phe Ser Cys Thr
Phe Ser Thr Cys
Phe Thr Cys Ser
Phe Thr Ser Cys
Gly Cys Asp Tyr
Gly Cys Phe Met
Gly Cys Met Phe
Gly Cys Tyr Asp
Gly Asp Cys Tyr
Gly Asp Glu His
Gly Asp His Glu
Gly Asp Tyr Cys
Gly Glu Asp His
Gly Glu His Asp
Gly Phe Cys Met
Gly Phe Met Cys
Gly His Asp Glu
Gly His Glu Asp
Gly Met Cys Phe
Gly Met Phe Cys
Gly Met Ser Tyr
Gly Met Tyr Ser
Gly Ser Met Tyr
Gly Ser Tyr Met
Gly Tyr Cys Asp
Gly Tyr Asp Cys
Gly Tyr Met Ser
Gly Tyr Ser Met
His Ala Asp Asp
His Cys Pro Thr
C18H28N6O6S (456.17909480000003)
His Cys Thr Pro
C18H28N6O6S (456.17909480000003)
His Asp Ala Asp
His Asp Asp Ala
His Asp Glu Gly
His Asp Gly Glu
His Glu Asp Gly
His Glu Gly Asp
His Gly Asp Glu
His Gly Glu Asp
His Pro Cys Thr
C18H28N6O6S (456.17909480000003)
His Pro Thr Cys
C18H28N6O6S (456.17909480000003)
His Thr Cys Pro
C18H28N6O6S (456.17909480000003)
His Thr Pro Cys
C18H28N6O6S (456.17909480000003)
Met Cys Cys Thr
Met Cys Phe Gly
Met Cys Gly Phe
Met Cys Thr Cys
Met Phe Cys Gly
Met Phe Gly Cys
Met Gly Cys Phe
Met Gly Phe Cys
Met Gly Ser Tyr
Met Gly Tyr Ser
Met Ser Gly Tyr
Met Ser Tyr Gly
Met Thr Cys Cys
Met Tyr Gly Ser
Met Tyr Ser Gly
Pro Cys His Thr
C18H28N6O6S (456.17909480000003)
Pro Cys Thr His
C18H28N6O6S (456.17909480000003)
Pro His Cys Thr
C18H28N6O6S (456.17909480000003)
Pro His Thr Cys
C18H28N6O6S (456.17909480000003)
Pro Thr Cys His
C18H28N6O6S (456.17909480000003)
Pro Thr His Cys
C18H28N6O6S (456.17909480000003)
Ser Cys Phe Thr
Ser Cys Thr Phe
Ser Phe Cys Thr
Ser Phe Thr Cys
Ser Gly Met Tyr
Ser Gly Tyr Met
Ser Met Gly Tyr
Ser Met Tyr Gly
Ser Thr Cys Phe
Ser Thr Phe Cys
Ser Tyr Gly Met
Ser Tyr Met Gly
Thr Ala Cys Tyr
Thr Ala Tyr Cys
Thr Cys Ala Tyr
Thr Cys Cys Met
Thr Cys Phe Ser
Thr Cys His Pro
C18H28N6O6S (456.17909480000003)
Thr Cys Met Cys
Thr Cys Pro His
C18H28N6O6S (456.17909480000003)
Thr Cys Ser Phe
Thr Cys Tyr Ala
Thr Phe Cys Ser
Thr Phe Ser Cys
Thr His Cys Pro
C18H28N6O6S (456.17909480000003)
Thr His Pro Cys
C18H28N6O6S (456.17909480000003)
Thr Met Cys Cys
Thr Pro Cys His
C18H28N6O6S (456.17909480000003)
Thr Pro His Cys
C18H28N6O6S (456.17909480000003)
Thr Ser Cys Phe
Thr Ser Phe Cys
Thr Tyr Ala Cys
Thr Tyr Cys Ala
Tyr Ala Cys Thr
Tyr Ala Thr Cys
Tyr Cys Ala Thr
Tyr Cys Asp Gly
Tyr Cys Gly Asp
Tyr Cys Thr Ala
Tyr Asp Cys Gly
Tyr Asp Gly Cys
Tyr Gly Cys Asp
Tyr Gly Asp Cys
Tyr Gly Met Ser
Tyr Gly Ser Met
Tyr Met Gly Ser
Tyr Met Ser Gly
Tyr Ser Gly Met
Tyr Ser Met Gly
Tyr Thr Ala Cys
Tyr Thr Cys Ala
2-ETHOXYCARBONYL-2-ETHOXYOXALOYLOXYDIHYDROCHRYSIN DIMETHYL ETHER
15-keto Fluprostenol
C23H27F3O6 (456.17596380000003)
Atrovirinone
3-O-(4-Methylgalloyl)epicatechin
9a-hydroxy-2,2,6,8,10,12b-hexamethyl-15-methylene-6a,7,8,9a,10,12b,13,13a-octahydro-2H,9H,12H-6,13-epoxy-8,12a-methanofuro[3,4:6,7]oxireno[2,3:3,4]heptaleno[3,2-c]pyran-4,9,12(6H)-trione
(-)-ecg-3-o-me
A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epicatechin.
1H-1-Benzazepine-1-aceticacid,3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3,4,5-tetrahydro-2-oxo-(9CI)
2-((4-(METHYLTHIO)PHENYL)AMINO)-1-(2-(TRIFLUOROMETHYL)BENZYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE
C23H19F3N4OS (456.12316000000004)
Methyl 5-acetamido-7,8,9-O-triacetyl-2,6-anhydro-4-azido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonate
C18H24N4O10 (456.14923639999995)
3-[ethyl[4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]amino]-N-(2-hydroxyethyl)-N-methylpropionamide
n,n-methanetetraylbis[4-[(4-isocyanatophenyl)methyl]-benzenamin
BRAF inhibitor
C22H18F2N4O3S (456.10676219999993)
BRAF inhibitor is a B-Raf inhibitor extracted from patent WO/2011103196 A1, Compound P-0850.
(+)-JQ-1
Azilsartan
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Azilsartan (TAK-536) is an orally active, potent, selective and specific angiotensin II type 1 receptor (AT1) antagonist. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. Azilsartan can be used for hypertension and stroke research[1][2][3][4][5].
5-(8-AMINO-7-CHLORO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-5-YL)-3-(1-PHENETHYLPIPERIDIN-4-YL)-1,3,4-OXADIAZOL-2(3H)-ONE
AZD 3988
C23H22F2N4O4 (456.16090360000004)
AZD3988 is an orally active diacylglycerol acyl transferase-1 (DGAT-1) inhibitor. AZD3988 has excellent DGAT-1 (human) potency with an IC50 value of 0. 6 nM. AZD3988 can be used for the research of metabolic diseases such as diabetes, obesity[1].
Macozinone
C20H23F3N4O3S (456.14428840000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
2-Deoxy-3,4-Bis-O-[3-(4-Hydroxyphenyl)propanoyl]-L-Threo-Pentaric Acid
Flavin mononucleotide semiquinone
C17H21N4O9P (456.10461060000006)
(S)-(+)-Tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
2-benzyl-3-(4-chlorophenyl)-5-(4-nitrophenyl)pyrazolo[1,5-a]pyrimidin-7(4H)-one
1,7-Bis(3,4,5-trimethoxyphenyl)hepta-1,6-diene-3,5-dione
Riboflavine 5-(dihydrogen phosphate)
C17H21N4O9P (456.10461060000006)
5-(3-Morpholin-4-YL-propyl)-2-(3-nitro-phenyl)-4-thioxo-4,5-dihydro-1-thia-3B,5-diaza-cyclopenta[A]pentalen-6-one
S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate
C17H33N2O8PS (456.16951480000006)
Dilmapimod
C23H19F3N4O3 (456.14091800000006)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
6-(2-bromo-3,6-dimethoxyphenyl)-9,9-dimethyl-6,8,10,11-tetrahydro-5H-benzo[b][1,4]benzodiazepin-7-one
C23H25BrN2O3 (456.10484399999996)
Tert-butyl 4-[4-[5-(4-chlorophenyl)thiophen-2-yl]pyrimidin-2-yl]piperazine-1-carboxylate
2,15-Dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-1(26),3(30),4,6,10(29),11,13,16(21),17,19,24,27-dodecaene-4,5,8,17-tetrol
3-Hydroxy-9-methoxy-6-oxo-8-pentanoyl-1-pentylbenzo[b][1,4]benzodioxepine-2-carboxylic acid
(1S,4aS,11aR,12aS)-3-carbamoyl-10-(dimethylamino)-1-(dimethylazaniumyl)-4a,7-dihydroxy-4,6-dioxo-1,4,4a,6,11,11a,12,12a-octahydrotetracene-2,5-diolate
C23H26N3O7- (456.17706660000005)
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(Z)-N-hydroxy-C-[(4-hydroxyphenyl)methyl]carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
2-[[4-(3-amino-1-oxo-5,6,6a,7-tetrahydro-2H-imidazo[1,5-f]pteridin-10-ium-8-yl)benzoyl]amino]pentanedioic acid
methyl 4-(hydroxymethyl)-5-oxo-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[4a,7a-dihydro-1H-cyclopenta[c]pyran-7,2-furan]-4-carboxylate
4-o-Methylepicatechin-3-o-gallate
A natural product found in Parapiptadenia rigida.
S-hexanoyl-4-phosphopantetheine
C17H33N2O8PS (456.16951480000006)
An S-acyl-4-phosphopantetheine obtained by formal condensation of the thiol group of D-pantetheine 4-phosphate with the carboxy group of hexanoic acid.
5,12-Bis(4-hydroxyphenyl)-5,12-diazapentacyclo[7.5.2.02,8.03,7.010,14]hexadec-15-ene-4,6,11,13-tetrone
(2E)-2-(4-methylbenzylidene)-6-[4-(2-pyridyl)piperazine-1-carbonyl]-4H-1,4-benzothiazin-3-one
6-methyl-3-[[[1-(phenylmethyl)-5-tetrazolyl]methyl-(thiophen-2-ylmethyl)amino]methyl]-1H-quinolin-2-one
6-[4-Oxo-2-[(4-oxo-2-pyrido[1,2-a]pyrimidinyl)methylthio]-3-thieno[3,2-d]pyrimidinyl]hexanoic acid
3-(3-Chlorophenyl)-1-[(1-methyl-3-indolyl)methyl]-1-[3-(4-morpholinyl)propyl]thiourea
C24H29ClN4OS (456.17504940000003)
N-[1,4-dimethyl-2,3-dioxo-7-(1-piperidinyl)-6-quinoxalinyl]-4-ethylbenzenesulfonamide
C23H28N4O4S (456.18311680000005)
N-[(3Z)-3-[1-cyano-2-[2-(4-methoxyphenyl)ethylamino]-2-oxoethylidene]isoindol-1-yl]thiophene-2-carboxamide
C25H20N4O3S (456.12560500000006)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methylanilino]acetamide
3-[2-[4-(4-Chlorophenyl)sulfonyl-1-piperazinyl]-2-oxoethyl]-5-(2-methylpropyl)imidazolidine-2,4-dione
C19H25ClN4O5S (456.12341100000003)
4-(1-Piperidinyl)-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]benzoic acid ethyl ester
C21H23F3N2O4S (456.13305540000005)
7-(6-O-beta-D-Xylopyranosyl-beta-D-glucopyranosyloxy)coumarin
1-[[(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
(6R,7R,8S)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-(4-((E)-styryl)phenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
alpha-L-rhamnosyl-(1->2)-alpha-L-rhamnosyl-(1->2)-alpha-L-rhamnose
alpha-D-rhamnopyranosyl-(1->2)-alpha-D-rhamnopyranosyl-(1->3)-alpha-D-rhamnopyranose
alpha-D-rhamnopyranosyl-(1->3)-alpha-D-rhamnopyranosyl-(1->2)-alpha-D-rhamnopyranose
alpha-D-abequosyl-(1->3)-alpha-D-mannosyl-(1->4)-alpha-L-rhamnose
alpha-D-rhamnopyranosyl-(1->2)-[alpha-D-rhamnopyranosyl-(1->3)]-alpha-D-rhamnopyranose
2-[(2R,4aS,12aR)-8-[[(2-fluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
C24H25FN2O6 (456.16965619999996)
[(3aR,4S,9bR)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
1-[[(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
2-[(2S,4aS,12aS)-8-[[(2-fluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
C24H25FN2O6 (456.16965619999996)
1-[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
2-[(2S,4aS,12aR)-8-[[(2-fluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
C24H25FN2O6 (456.16965619999996)
2-[(2S,4aR,12aR)-8-[[(2-fluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
C24H25FN2O6 (456.16965619999996)
[(3aR,4R,9bR)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4R,9bR)-8-(2-fluorophenyl)-5-methyl-1-[(4-methyl-4H-imidazol-2-yl)sulfonyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C23H25FN4O3S (456.16313119999995)
[(3aS,4S,9bS)-8-(2-fluorophenyl)-5-methyl-1-[(4-methyl-4H-imidazol-2-yl)sulfonyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C23H25FN4O3S (456.16313119999995)
[(3aS,4S,9bS)-8-(2-fluorophenyl)-1-(2-fluorophenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
C24H22F2N2O3S (456.1319126000001)
[(3aR,4S,9bR)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(3-fluorophenyl)methanone
[(1S)-1-(hydroxymethyl)-7-methoxy-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(2-thiazolylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C23H28N4O4S (456.18311680000005)
[(1R)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(2-pyridinyl)methanone
(6R,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
2-[(2R,4aR,12aR)-8-[[(2-fluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
C24H25FN2O6 (456.16965619999996)
2-[(2R,4aR,12aS)-8-[[(2-fluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
C24H25FN2O6 (456.16965619999996)
[(3aS,4R,9bS)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-8-(2-fluorophenyl)-5-methyl-1-[(4-methyl-4H-imidazol-2-yl)sulfonyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C23H25FN4O3S (456.16313119999995)
[(3aS,4R,9bS)-8-(2-fluorophenyl)-5-methyl-1-[(4-methyl-4H-imidazol-2-yl)sulfonyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C23H25FN4O3S (456.16313119999995)
[(3aR,4R,9bR)-8-(2-fluorophenyl)-1-(2-fluorophenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
C24H22F2N2O3S (456.1319126000001)
[(3aS,4R,9bS)-8-(2-fluorophenyl)-1-(2-fluorophenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
C24H22F2N2O3S (456.1319126000001)
[(3aR,4S,9bR)-8-(2-fluorophenyl)-1-(2-fluorophenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
C24H22F2N2O3S (456.1319126000001)
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(3-fluorophenyl)methanone
[(1R)-1-(hydroxymethyl)-7-methoxy-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(2-thiazolylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C23H28N4O4S (456.18311680000005)
[(1S)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(2-pyridinyl)methanone
(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
4-(1-Benzofuran-2-carbonyl)-1-(5-methyl-1,2-oxazol-3-yl)-5-(3-prop-2-enoxyphenyl)pyrrolidine-2,3-dione
3,4,5-Trihydroxy-6-[(4,5,6-trihydroxy-2-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}oxan-3-yl)oxy]oxane-2-carboxylic acid
C16H24O15 (456.11151540000003)
3,4,5-trihydroxy-6-[(E)-5-oxo-1,7-diphenylhept-1-en-3-yl]oxyoxane-2-carboxylic acid
6-[2,3-dihydroxy-3-methyl-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-7-methoxychromen-2-one
C21H28O11 (456.16315380000003)
FMNH2(2-)
C17H21N4O9P (456.10461060000006)
Dianion of reduced flavin mononucleotide arising from deprotonation of both phosphate OH groups.
(6R)-5,10-Methenyltetrahydrofolic acid
The 5,10-methenyl derivative of tetrahydrofolic acid arising from enzymatic cyclisation of 5-formyltetrahydrofolic acid.
minocycline(1-)
C23H26N3O7 (456.17706660000005)
An organic anion that is the conjugate base of minocycline, obtained by deprotonation of the two enolic hydroxy groups and protonation of the non-aromatic tertiary amino group.